Figure 1
From: Quantity of IgG response to SARS-CoV-2 spike glycoprotein predicts pulmonary recovery from COVID-19
Qualitative and quantitative results for S-specific IgG correlate with the clinical severity of COVID-19. Patients were categorized according to clinical severity of acute COVID-19 (Nmild = 36, Nmoderate = 37, Nsevere = 40, Ncritical = 32). For each clinical category of disease severity, the relative abundance of patients (A) who mounted a substantial IgG response against the S glycoprotein above the cut-off threshold is depicted. The SARS-CoV-2 IgG concentrations were quantified (B) at the 60 days follow-up according to acute disease severity categories. p-values were calculated with the Kruskal–Wallis test.
